Zai Lab Announces Upcoming Presentations at June Investor Conferences

Rhea-AI Summary

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) announced its participation in two major investor conferences in June 2022, aimed at enhancing investor relations. Management will present at the Jefferies Global Healthcare Conference on June 9 at 9:00 a.m. ET, followed by a Fireside Chat at the Goldman Sachs 43rd Annual Global Healthcare Conference on June 16 at 9:20 a.m. PT. These presentations will be accessible via webcast on the company’s website, with archived replays available for 90 days. Zai Lab focuses on innovative therapies for oncology, autoimmune disorders, and infectious diseases.

SHANGHAI and SAN FRANCISCO and CAMBRIDGE, Mass., May 24, 2022 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), a patient-focused, innovative, commercial-stage, global biopharmaceutical company, today announced that management from Zai Lab will be presenting at the following investor conferences in June:

Jefferies Global Healthcare Conference 2022
Presentation: Thursday, June 9, 2022, 9:00 a.m. ET

Goldman Sachs 43rd Annual Global Healthcare Conference
Fireside Chat: Thursday, June 16, 2022, 9:20 a.m. PT

Webcast links of the conferences will be available under “Events & Presentations” in the “Investor Relations” section of Zai Lab’s website. An archived replay will be viewable after the presentation for the following 90 days.

About Zai Lab

Zai Lab (NASDAQ: ZLAB; HKEX: 9688) is a patient-focused, innovative, commercial-stage, global biopharmaceutical company focused on developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders, infectious diseases, and neuroscience. To that end, our experienced team has secured partnerships with leading global biopharmaceutical companies to generate a broad pipeline of innovative marketed products and product candidates. We have also built an in-house team with strong product discovery and translational research capabilities and are establishing a pipeline of proprietary product candidates with global rights. Our vision is to become a leading global biopharmaceutical company, discovering, developing, manufacturing, and commercializing our portfolio to impact human health worldwide.

For additional information about Zai Lab, please visit www.zailaboratory.com or follow us at www.twitter.com/ZaiLab_Global.

For more information, please contact:

ZAI LAB CONTACTS:

Investor Relations: Lina Zhang
+86 136 8257 6943
lina.zhang@zailaboratory.com

Media: Danielle Halstrom / Xiaoyu Chen
+1 (215) 280-3898 / +86 185 0015 5011
danielle.halstrom@zailaboratory.com / xiaoyu.chen@zailaboratory.com 

Zai Lab Limited

Source: Zai Lab Limited

FAQ

What conferences will Zai Lab present at in June 2022?

Zai Lab will present at the Jefferies Global Healthcare Conference on June 9, 2022, and participate in a Fireside Chat at the Goldman Sachs 43rd Annual Global Healthcare Conference on June 16, 2022.

What is the date and time for Zai Lab's presentation at the Jefferies Global Healthcare Conference?

Zai Lab's presentation at the Jefferies Global Healthcare Conference is scheduled for June 9, 2022, at 9:00 a.m. ET.

When will Zai Lab's Fireside Chat at Goldman Sachs take place?

Zai Lab's Fireside Chat at the Goldman Sachs 43rd Annual Global Healthcare Conference will occur on June 16, 2022, at 9:20 a.m. PT.

How can investors access Zai Lab's conference presentations?

Investors can access Zai Lab's conference presentations via webcast links available in the 'Events & Presentations' section of the company's website.

What therapeutic areas does Zai Lab focus on?

Zai Lab focuses on developing therapies for oncology, autoimmune disorders, infectious diseases, and neuroscience.